NF1 splicing reprograms ERα signaling to promote luminal breast cancer progression
Patrick S. Dischinger, Ian Beddows, Sophia Agrusa…·Matthew R. Steensma
This paper identifies an alternatively spliced NF1 isoform, NLS SE, that promotes luminal breast cancer progression by disrupting nuclear neurofibromin function and reprogramming ER signaling toward post-transcriptional regulation.